NCT00794443View on ClinicalTrials.gov

ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

692

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
OsteoporosisBone Loss, Age-Related
Interventions
DRUG

YM529 / ONO-5920

Oral

Trial Locations (5)

Unknown

Hokkaido

Kansai

Kantou

Kyusyu

Shikoku

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00794443 - ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients | Biotech Hunter | Biotech Hunter